Immunovant, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| IMVT | ROIV | ABCL | DNTH | IOVA | PTGX | |
|---|---|---|---|---|---|---|
| Market cap | 6.09B | 24.99B | 4.09B | 4.56B | 6.60B | 9.37B |
| P/E (TTM) | — | — | — | — | — | 140.7 |
| Forward P/E | -10.7 | -20.1 | -16.6 | -17.7 | -67.9 | -727.5 |
| Price/book | 8.3 | 5.9 | 4.3 | 3.8 | 9.0 | 11.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +75.62% | +118.63% | +122.84% | +139.31% | +583.18% | +81.55% |
| Today | −3.25% | −2.40% | +0.72% | −0.97% | −0.41% | +0.80% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All IMVT news ›IMVT Investors with $100,000 in Losses Have Opportunity to Join Immunovant, Inc. Fraud Investigation with SBS Law
The National Law Review IMVT Investors with $100,000 in Losses Have Opportunity to Join Immunovant, Inc. Fraud Investigation with SBS Law LOS ANGELES--(BUSINESS WIRE)--$IMVT--Schall, Brown & Schwartz LLP (“SBS”), a national shareholder…
Bronstein, Gewirtz & Grossman, LLC Initiate an Investigation into Allegations Against Immunovant, Inc. (IMVT) And Encourages Shareholders to Reach Out
Sunday, 11 October 2026 01:00 PM On September 23, 2026, Immunovant announced that its proof-of-concept study of IMVT-1402 in cutaneous lupus erythematosus did not achieve statistical significance on its primary endpoint. The company said…
Immunovant (NASDAQ:IMVT) CEO Sells $119,589.66 in Stock
Posted by Kim Johansen on Oct 8th, 2026 Shares of NASDAQ:IMVT opened at $32.04 on Thursday. The company has a market capitalization of $6.62 billion, a price-to-earnings ratio of -11.36 and a beta of 0.84. The firm’s 50 day simple moving…
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Immunovant, Inc. (IMVT) and Encourages Stockholders to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga The National Law Review Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Immunovant, Inc. (IMVT) and Encourages Stockholders to Learn More About the…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
natlawreview.com2
-
accessnewswire.com1
-
biopharmadive.com1
-
biospace.com1
-
businesswire.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 8 articles, not a forecast.